Skip to main content

Royal London Asset Management Ltd

Source: SEC Form 13F · as of Mar 2026

Royal London Asset Management Ltd holds 39 biotech & pharma companies tracked by BioSniper, totaling $5.36B in value as of Mar 2026 (SEC Form 13F).

Companies held

39

Total value held

$5.36B

BioSniper AIPage evidence connected

Prepared research question

What matters most for ASTRAZENECA PLC (AZN)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
AZNASTRAZENECA PLC10,299,563$2.03B
LLYELI LILLY & Co656,585$603.9M
MRKMerck & Co., Inc.2,896,154$348.4M
JNJJOHNSON & JOHNSON1,202,690$294.0M
ABBVAbbVie Inc.1,351,717$294.0M
UNHUnitedHealth Group Incorporated Common Stock (DE)755,589$204.5M
PMPhilip Morris International Inc1,214,925$200.9M
RPRXRoyalty Pharma plc3,808,353$182.7M
VRTXVERTEX PHARMACEUTICALS INC / MA252,192$112.6M
GMOptec International, Inc.1,420,813$105.9M
HALOHALOZYME THERAPEUTICS, INC.1,610,553$104.1M
AMGNAMGEN INC281,362$99.0M
MCKMcKesson Corporation111,025$96.1M
ABTABBOTT LABORATORIES807,949$83.0M
GILDGILEAD SCIENCES, INC.571,333$79.6M
PFEPFIZER INC2,823,465$79.3M
ALNYALNYLAM PHARMACEUTICALS, INC.215,075$71.2M
ELVElevance Health Inc.235,180$68.8M
BMYBRISTOL MYERS SQUIBB CO903,602$54.8M
CAHCardinal Health Inc.166,378$35.2M
CORCencora Inc.108,231$34.0M
IDXXIDEXX LABORATORIES INC /DE51,028$28.7M
ZTSZoetis Inc.227,354$26.9M
WSTWest Pharmaceutical Services Inc.99,550$25.0M
INCYIncyte Corp.192,049$18.1M
GEHCGE HealthCare Technologies Inc.227,183$16.2M
IQVIQVIA Holdings Inc.78,478$13.4M
BIIBBIOGEN INC.64,266$11.8M
DGXQuest Diagnostics Incorporated51,570$10.1M
ZBHZimmer Biomet Holdings Inc.91,118$8.2M
NBIXNEUROCRINE BIOSCIENCES INC54,763$7.2M
MOHMolina Healthcare Inc26,191$3.5M
REGNREGENERON PHARMACEUTICALS, INC.3,919$3.0M
INSMINSMED Inc14,498$2.4M
TEVATeva Pharmaceutical Industries Limited50,572$1.5M
LEGNLegend Biotech Corp75,000$1.4M
QGENQIAGEN N.V.32,444$1.3M
UTHRUNITED THERAPEUTICS Corp1,679$996K
RVMDREVOLUTION MEDICINES, INC.3,142$306K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.